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Study objectives: To assess and compare the smoking cessation practices and smoking
behavior of Dutch general practitioners (GPs), cardiologists, and lung physicians.
Methods: We conducted questionnaire surveys among a random sample of 2000 Dutch
GPs, all Dutch cardiologists ðN ¼ 594Þ, and all Dutch lung physicians ðN ¼ 375Þ.
Results: In total, 834 GPs (41.7%), 300 cardiologists (50.5%), and 258 lung physicians (68.8%)
filled out and returned the questionnaire. The prevalence of current smokers was 8.2% among
GPs, 4.3% among cardiologists, and 3.5% among lung physicians. Of the pharmacological aids
for smoking cessation, physicians recommended bupropion most frequently, followed by
nicotine patches and nicotine gum. More lung physicians recommended the use of these three
aids (67.0%, 36.3% and 18.2%, respectively) than GPs (65.7%, 18.7% and 9.8%, respectively),
and than cardiologists (31.6%, 19.7% and 13.2%, respectively). A higher proportion of lung
physicians (69.3%) had referred at least one smoker to a nurse for smoking cessation
treatment than cardiologists (25%), and than GPs (11.3%).
Conclusions: Based on this national survey, one may conclude that the prevalence of
current smoking among Dutch physicians is relatively low and has further decreased since
1988. Dutch GPs, cardiologists, and lung physicians mainly use interventions for smoking
cessation that are easy to administer and are not very time consuming. Furthermore, more
lung physicians than GPs and cardiologists recommend the use of bupropion, nicotine
patch, and nicotine gum. When designing interventions for smoking cessation, one should
take into account that physicians are often reluctant to provide interventions which
demand much time. Therefore, intensive counseling of smokers who want to quit smoking
may be more feasible for trained non-physicians, such as nurses.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Smoking cessation practices of Dutch physicians 569Introduction Questionnaire development and contentInternational smoking cessation guidelines recommend that
health professionals should assess the smoking status of their
patients and advise smokers to stop.1–3 They should also
facilitate a quit attempt by recommending the use of
pharmacotherapy (bupropion, nicotine replacement ther-
apy), offering brief counseling, and arranging follow-up
visits when appropriate. According to the recently devel-
oped Dutch guideline on the treatment of tobacco depen-
dence,4 general practitioners (GPs) can play an important
role in reducing smoking prevalence because about 75% of
the population consult their GP at least once a year.5
Specialists, such as lung physicians and cardiologists, could
well use hospitalization as an opportunity to encourage their
patients to stop smoking.3,6 Not only because the illness or
condition resulting in hospitalization may have been caused
or complicated by smoking, highlighting the patient’s
personal vulnerability to the health risks of smoking, but
also because hospitalized smokers are temporarily housed in
a smoke-free environment, offering unique opportunities for
cessation treatment.
In the Netherlands, few data is available about the
practice of GPs, cardiologists, and lung physicians regarding
the treatment of tobacco dependence. We could only find
one study, conducted almost 20 years ago, describing the
smoking cessation practice of Dutch GPs.7 Since then, new
smoking cessation methods have been developed and
several reviews into their effectiveness have been pub-
lished.8–12
We conducted three questionnaire surveys among a
random sample of Dutch GPs, all Dutch cardiologists, and
all Dutch lung physicians to assess and compare the smoking
cessation practices and smoking behavior of these health
professionals.Methods
Questionnaire administration
From May 2002 through January 2003, we conducted
questionnaire surveys including a random sample of 2000
GPs (approximately 27% of all registered GPs in the Nether-
lands), all 594 Dutch cardiologists, and all 375 Dutch lung
physicians. Electronic files with the names and addresses of
registered GPs, cardiologists, and lung physicians were
provided by the Netherlands Institute of Health Services
Research (NIVEL), the Dutch Society of Cardiology (NVVC),
and the Dutch Thoracic Society (NVALT), respectively. We
used a personalized introduction letter explaining the
objectives of the study and stamped addressed envelopes.
Regarding the surveys among cardiologists and lung physi-
cians, we repeatedly sent mailed reminders with an
abridged version of the questionnaire to all non-responders
in order to increase the response rate. Regarding the survey
among GPs, we did not use mailed reminders. Instead, we
sent a questionnaire containing only questions on smoking
behavior to a random sample of 100 GPs from the non-
response group. A gift voucher of EUR 5,- (USD 6,52) was
sent along.The questionnaire consisted of three parts and was pre-
tested by epidemiologists and physicians. Its completion
time turned out to be 5–10min. The first part contained
questions about the physicians demographic and work-
related characteristics. In the second part, we asked which
of the existing pharmacotherapeutical and behavioral
interventions for smoking cessation they had used and how
many smokers they had advised to stop smoking. In order to
minimize recall bias, these questions referred to the last 4
weeks preceding the questionnaire. In the third part, we
asked the physicians about their own smoking status. We
defined ‘‘current smokers’’ as those physicians who reported
to smoke cigarettes every day or occasionally. ‘‘Past
smokers’’ were those non-smokers who used to smoke
cigarettes every day or occasionally in the past. ‘‘Never
smokers’’ were those non-smokers who had never smoked
cigarettes.
Data analysis
We used Mann–Whitney U-tests to compare the mean
number of smokers that were advised to stop smoking by
GPs, cardiologists, and lung physicians. Overall w2 tests were
performed to compare the frequency of reporting the use of
pharmacotherapeutical and behavioral interventions for
smoking cessation between the three study groups. In case
of a statistically significant overall test (Po0.05), pair-wise
w2 tests were performed in order to determine which of the
study groups differed from one another. Likewise, w2 tests
were performed to compare the smoking status of the study
groups. In case less than 80% of cells had expected values of
at least 5, Fisher’s exact test was used to determine
P-values. Cases were excluded analysis-by-analysis (e.g. a
case was excluded only for the analysis in which it had a
missing value). All analyses were performed using the
Statistical Package for Social Sciences (SPSS) 11.0.
Results
Response
In total, 758 GPs (37.9%) filled out and returned the
questionnaire. 76 GPs (76%) from the non-response group
filled out and returned the short questionnaire containing
only questions on smoking behavior. From the 594 Dutch
cardiologists, 300 (50.5%) filled out and returned a ques-
tionnaire. Thirty-five cardiologists returned the long version
of the questionnaire containing questions about pharmaco-
logical and behavioral interventions as well as smoking
behavior. Forty-one cardiologists returned the abridged
version of the questionnaire containing questions about
pharmacological and behavioral interventions only. One
hundred and twenty-nine cardiologists returned the
abridged version of the questionnaire containing questions
about smoking behavior only. Of the 375 lung physicians, 258
(68.8%) filled out and returned a questionnaire. Two hundred
and sixteen lung physicians returned the abridged version of
the questionnaire containing questions about pharmacolo-
gical and behavioral interventions only.
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Table 1 shows the demographic and work-related character-
istics of the three study groups. 69.3% ðn ¼ 525Þ of the GPs
were male, compared to 88.3% ðn ¼ 264Þ of the cardiologists
and 82.6% ðn ¼ 213Þ of the lung physicians. The mean ages in
the three samples were 45.9 (SD ¼ 7.3), 48.3 (SD ¼ 7.1), and
47.0 years (SD ¼ 7.0), respectively.
Number of smokers advised to stop smoking
On average, GPs had advised 9.2 patients (SD ¼ 9.4) to stop
smoking during the 4 weeks preceding the questionnaire.
Cardiologists had advised 24.3 patients to do so (SD ¼ 30.0), a
significant difference compared to GPs (Z ¼ 12:74,
Po0.001). Lung physicians had advised 38.8 patients
(SD ¼ 40.9), significantly more than cardiologists (Z ¼
4:26, Po0.001) and GPs (Z ¼ 13:83, Po0.001).
Recommendation or prescription of
pharmacotherapy for smoking cessation
Table 2 shows the number and percentage of physicians who
had prescribed or recommended pharmacotherapy for
smoking cessation at least once during the 4 weeks
preceding the questionnaire. The use of bupropion had
been recommended most frequently, followed by nicotineTable 1 Demographic and work-related characteristics of the
Characteristics GPs
ðn ¼ 758Þ
Sex male, n (valid percentage) 525 (69.3)
Age, mean (SD) 45.9 (7.3)
Setting, n (valid percentage)
Solo practice 273 (36.4)
Duo practice 270 (36.0)
Group practice 208 (27.7)
University hospital n/a
District hospital n/a
Other n/a
n=a;Not applicable.
Table 2 Number and valid percentage of physicians who had
cessation at least once during the preceding 4 weeks.
Pharmacotherapy GPs Cardiologists
ðn ¼ 758Þ ðn ¼ 76Þ
Bupropion 495 (65.7) 24 (31.6)
Nicotine patch 139 (18.7) 15 (19.7)
Nicotine gum 72 (9.8) 10 (13.3)
The overall test compares the proportion of yes/no responders apatches and nicotine gum. The use of bupropion had been
recommended by a significantly higher proportion of lung
physicians (n ¼ 124, 67.0%, w2 ¼ 27:57, df ¼ 1, Po0.001)
and GPs (n ¼ 495, 65.7%, w2 ¼ 34:41, df ¼ 1, Po0.001),
than cardiologists (n ¼ 24, 31.6%). The use of nicotine
patches had been recommended by a significantly higher
proportion of lung physicians (n ¼ 66, 36.3%) than GPs
(n ¼ 139, 18.7%, w2 ¼ 26:12, df ¼ 1, Po0.001), and than
cardiologists (n ¼ 15, 19.7%, w2 ¼ 6:80, df ¼ 1, Po0.01).
The use of nicotine gum had been recommended by a
significantly higher proportion of lung physicians (n ¼ 33,
18.2%) than GPs (n ¼ 72, 9.8%, w2 ¼ 10:18, df ¼ 1, Po0.01).
Only a few GPs and lung physicians, and no cardiologists had
prescribed or recommended nortriptyline, nicotine tablet,
microtab (sublingual tablet), or nicotine inhaler.
We further analyzed differences in demographic and
work-related characteristics with regard to the prescription
of pharmacotherapy. We limited the analysis to the
prescription of bupropion because it had been recom-
mended most frequently. This stratification was only
suitable for the GP data which included a large number
respondents. There were no significant differences in the
prescription of bupropion concerning sex, age, and smoking
status. However, significantly more GPs working in a solo
practice (n ¼ 198, 73.1%) had prescribed bupropion than
GPs working in a duo practice (n ¼ 160, 59.5%) and than GPs
working in a group practice (n ¼ 134, 64.7%, w2 ¼ 11:24,
df ¼ 2, Po0.01).three study groups.
Cardiologists Lung physicians
ðn ¼ 300Þ ðn ¼ 258Þ
264 (88.3) 213 (82.6)
48.3 (7.1) 47.0 (7.0)
n/a n/a
n/a n/a
n/a n/a
53 (17.7) 47 (18.2)
231 (77.5) 190 (73.6)
14 (4.7) 21 (8.2)
prescribed or recommended pharmacotherapy for smoking
Lung physicians Overall w2 test and P-value
ðn ¼ 216Þ
124 (67.0) w2 ¼ 35:99, df ¼ 2, Po0.001
66 (36.3) w2 ¼ 26:52, df ¼ 2, Po0.001
33 (18.2) w2 ¼ 10:31, df ¼ 2, Po0.01
cross the three study groups.
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cessation
Table 3 shows the numbers and percentages of physicians
who had used behavioral interventions for smoking cessation
at least once during the 4 weeks preceding the question-
naire. Three hundred and sixty-six GPs (48.6%), 38 cardiol-
ogists (50.0%), and 85 lung physicians (42.3%) had provided
smokers with self-help materials. Two hundred and forty-
three GPs (32.4%), 19 cardiologists (25.0%), and 53 lung
physicians (26.9%) had used the minimal intervention
strategy (MIS), which is a minimum contact intervention
that health care providers can use to help smokers quit.
Significantly more lung physicians (n ¼ 142, 69.3%) had
referred at least one smoker to a nurse for smoking
cessation treatment than cardiologists (n ¼ 19, 25.0%,
w2 ¼ 44:41, df ¼ 1, Po0.001), and than GPs (n ¼ 85,
11.3%, w2 ¼ 298:2, df ¼ 1, Po0.001). Significantly more
cardiologists had referred smokers to a nurse than GPs
(w2 ¼ 11:71, df ¼ 1, Po0.001). We asked cardiologists and
lung physicians if they had referred any smokers to their GPs
for smoking cessation treatment. 36.8% ðn ¼ 75Þ of the lung
physicians and 42.1% ðn ¼ 32Þ of the cardiologists gave an
affirmative answer.Physicians’ smoking status
Table 4 shows the smoking status of Dutch GPs, lung
physicians, and cardiologists. The smoking prevalence wasTable 3 Number and valid percentage of physicians who had
once during the preceding 4 weeks.
Behavioral intervention GPs Cardiol
ðn ¼ 758Þ ðn ¼ 76
Providing smokers with self-help
material
366 (48.6) 38 (50.
Using minimal intervention
strategy (MIS)
243 (32.4) 19 (25.
Referring smokers to practice
nurse/pulmonary nurse
85 (11.3) 19 (25.
Referring smokers to telephone
counseling hotline
76 (10.1) 4 (5.
The overall test compares the proportion of yes/no responders a
Table 4 Number and valid percentage of current, past and ne
Smoking status General practitioners
ðn ¼ 758Þ
Current smoker 62 (8.2)
Past smoker 224 (29.7)
Never smoker 467 (62.0)
Smoking refers only to the use of cigarettes.highest among GPs (8.2%, n ¼ 62), and lowest among lung
physicians (3.5%, n ¼ 9). However, the prevalence of
smokers among Dutch GPs is assumed to be higher, since
the non-response analysis showed that 12 of the 76 (16%)
GPs reported that they currently smoked cigarettes. Only
the difference between GPs and lung physicians in the
distribution of current, past, and never smokers was
statistically significant (w2 ¼ 7:21, df ¼ 2, P ¼ 0:03).Discussion
The results from the questionnaire surveys we conducted
among Dutch GPs, lung physicians, and cardiologists showed
that of the pharmacological aids for smoking cessation,
physicians recommended bupropion most frequently. In
comparison with cardiologists, almost twice as many GPs
and lung physicians recommended the use of this pharma-
cological aid. Among the nicotine replacement therapies,
the patch and the gum were most popular, although they
were much less frequently recommended by Dutch physi-
cians than bupropion. Results also indicated that behavioral
interventions for smoking cessation were used not very
often. The most frequently used behavioral interventions
were those which are not very time-consuming: providing
self-help materials and referring smokers to a nurse for
further treatment. The prevalence of current smokers
among Dutch physicians was relatively low. More GPs than
lung physicians were current smokers.used behavioral interventions for smoking cessation at least
ogists Lung physicians Overall w2 test
and P-value
Þ ðn ¼ 216Þ
0) 85 (42.3) w2 ¼ 2:75, df ¼ 2,
P ¼ 0:25
0) 53 (26.9) w2 ¼ 3:50, df ¼ 2,
P ¼ 0:17
0) 142 (69.3) w2 ¼ 297:5, df ¼ 2,
Po0.001
3) 20 (9.8) w2 ¼ 1:85, df ¼ 2,
P ¼ 0.40
cross the three study groups.
ver smokers among GPs, cardiologists, and lung physicians.
Cardiologists Lung physicians
ðn ¼ 164Þ ðn ¼ 258Þ
7 (4.3) 9 (3.5)
40 (24.8) 73 (28.5)
114 (70.8) 174 (68.0)
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compare the use of interventions for smoking cessation by
GPs, cardiologists, and lung physicians. We sent question-
naires to all Dutch lung physicians, all Dutch cardiologists,
and to a random sample of approximately 27% of all Dutch
GPs. Of the existing pharmacological aids for smoking
cessation, bupropion was by far the most popular among
Dutch physicians. One possible explanation might be that
bupropion is easy to use and does not demand much time
from the physician. This explanation is supported by our
finding that the behavioral interventions most commonly
used by physicians were self-help materials to support
smokers who want to quit, which are also easy to use and
are not very time-consuming. Bupropion was registered as a
therapy for smoking cessation in the Netherlands in 1999. The
marketing campaigns of the pharmaceutical company might
also explain that bupropion has been widely prescribed by
physicians, although the drug had some negative publicity in
the Netherlands in 2001 due to suspected adverse reac-
tions.13,14 Nortriptyline, a generic non-patent medicine, was
prescribed by very few physicians, though it has been shown
to be an efficacious and cheap alternative to bupropion.8,15
Sixty-nine percent of Dutch lung physicians and 25% of Dutch
cardiologists referred smokers to a pulmonary nurse for
assistance during a quit attempt. Assuming a dose–response
relation between the number and duration of counseling
sessions for tobacco dependence and their efficacy,16
pulmonary nurses can play an important role in helping
smokers to quit. One of the reasons is that they can probably
spend more time with a smoker than the physician.17
In the year 2004, shortly after our surveys, the Dutch
guideline for the treatment of tobacco dependence was
published.4 The national organizations of GPs (Dutch College
of General Practitioners, NHG), lung physicians (NVALT), and
cardiologists (NVVC) had participated in the development. To
what extent does the guideline reflect the reported practice
of the respondents to our surveys? According to the guideline,
health care providers should at least give smoking cessation
advice to every new smoking patient and should repeat this
annually. If one compares the number of smokers advised to
stop smoking with the number of (smoking) patients these
physicians are likely to see every month, one is lean to believe
that they do not give smoking cessation advice in every
smoking patient. The guideline states that both bupropion and
nortriptyline are effective and safe. However, due to their
side effects, both drugs should not be prescribed as an aid for
smoking cessation in the first place. Furthermore, prescription
should be combined with at least two consultations with the
physician. It remains doubtful, whether Dutch physicians (can)
do so. The guideline acknowledges that health care providers
have limited time for smoking cessation treatment. There-
fore, the guideline recommends that nurse practitioners
should be trained to become specialists for (intensive)
smoking cessation interventions.
Between 1956 and 1988, the prevalence of smoking among
Dutch GPs has decreased from 82% to 29%.18 A similar trend
has been found in Scandinavian countries.19 Although data on
the prevalence of smoking among Dutch GPs between 1988
and 2002 are lacking, our results seem to indicate that the
percentage of smoking GPs has decreased further. The
prevalence of current smokers was higher among GPs than
among lung physicians. One explanation might be that lungphysicians are more regularly confronted with smoking-
related diseases during daily practice. In the Netherlands,
the prevalence of smoking among physicians (about 4–8%) is
much lower than among the general population (34%).5 One
possible explanation for this might be that physicians see
themselves as role models for their patients by being non-
smokers and by creating a smoke-free work environment.20,21
The prevalence of current smokers among Dutch physicians
seems to be lower than in Germany (18%) and Japan (20%),
but still higher than in the USA (3%) and Finland (5%).22–24
This study was limited by the low-to-moderate response
rates of 38–69%. Although such response rates are not unusual
for studies in this field, one must be aware that selection bias
may has occurred. The demographic and work-related
characteristics of the three groups of respondents who
participated in this study were similar to those of the total
group of Dutch GPs, lung physicians and cardiologists.
Moreover, we did not find differences in the mean number
of patients advised to stop smoking by cardiologists and lung
physicians who returned the first questionnaire compared to
those who returned the reminder questionnaire. Never-
theless, if selection bias has occurred, it is likely that the
responders represent a group of physicians that is more active
in smoking cessation treatment than the non-responders. In
that case, the frequency of advice to quit smoking and of the
prescription of smoking cessation aids we found may be an
overestimation of the general situation. Our data may also
present an underestimation of the prevalence of current and
past smoking physicians. We found that the prevalence of
smoking GPs among the random sample of 76 GPs from the
non-response group was higher (16%) than the prevalence
among the total group of GPs who returned the question-
naire. We found a similar trend between early and late
responders in the groups of cardiologists and lung physicians.
We therefore expect the true prevalence of smoking
physicians to be slightly higher than the prevalence we
found. Data from cross-sectional studies with low response
rates should always be interpreted with care. However, in the
absence of studies with higher response rates, we think that
our data present valuable information about the comparison
of GPs, cardiologists, and lung physicians with regard to the
use of interventions for smoking cessation.
Based on this national survey, one may conclude that the
prevalence of current smoking among Dutch physicians is
relatively low and has further decreased since 1988. Dutch
GPs, cardiologists, and lung physicians mainly use interven-
tions for smoking cessation that are easy to administer and
are not very time consuming. Furthermore, more lung
physicians than GPs and cardiologists recommend the use of
bupropion, nicotine patch, and nicotine gum. When designing
interventions for smoking cessation, one should take into
account that physicians are often reluctant to provide
interventions which demand much time. Therefore, intensive
counseling of smokers who want to quit smoking may be more
feasible for trained non-physicians, such as nurses.Acknowledgments
This study was supported by a grant from the
Dutch ‘‘Partnership Stop-met-Roken [Partnership smoking
cessation].’’
ARTICLE IN PRESS
Smoking cessation practices of Dutch physicians 573References
1. West R, McNeill A, Raw M. Smoking cessation guidelines for
health professionals: an update. Thorax 2002;55(12):987–99.
2. Raw M, McNeill A, West R. Smoking cessation: evidence based
recommendations for the healthcare system. BMJ 1999;
318(7177):182–5.
3. US Department of Health and Human Services. Clinical Practice
Guideline, Treating Tobacco Use and Dependence, 2000.
4. Kwaliteitsinstituut voor de Gezondheidszorg CBO, Richtlijn
Behandeling van Tabaksverslaving. [Guideline treating tobacco
dependence]. Utrecht: Kwaliteitsinstituut voor de Gezond-
heidszorg CBO; 2004.
5. Centraal Bureau voor de Statistiek, Vademecum gezondheids-
statistiek Nederland 2003. [Basic guide to health statistics in
the Netherlands 2003]. Centraal Bureau voor de Statistiek:
Voorburg/Heerlen; 2004.
6. Orleans CT, Kristeller JL, Gritz ER. Helping hospitalized smokers
quit: new directions for treatment and research. J Consult Clin
Psychol 1993;61(5):778–89.
7. Dekker HM, et al. Rookgedrag van huisartsen, specialisten en
studenten in Rotterdam, 1989. [Smoking behavior of family
physicians, specialists and students in Rotterdam, 1989]. Ned
Tijdschr Geneeskd 1990;134(31):1495–8.
8. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking
cessation (Cochrane Review). In: The cochrane library, issue 3.
Wiley: Cichester, UK; 2004.
9. Lancaster T, Stead LF. Individual behavioural counselling for
smoking cessation (Cochrane Review). In: The cochrane library,
Issue 3. Cichester, UK: Wiley; 2004.
10. Silagy C, Stead LF. Physician advice for smoking cessation
(Cochrane Review). In: The cochrane library, Issue 1. Cichester,
UK: Wiley; 2004.
11. Stead LF, Lancaster T, Perera R. Telephone counselling for
smoking cessation (Cochrane Review). In: The cochrane library,
Issue 1. Cichester, UK: Wiley; 2004.
12. Stead LF, Lancaster T. Group behaviour therapy programmes for
smoking cessation (Cochrane Review). In: The cochrane library,
Issue 3. Cichester, UK: Wiley; 2004.
13. Wagena EJ, et al. Onrust over de veiligheid van bupropion als
middel om te stoppen met roken onterecht. [Uneasiness aboutthe safety of bupropion as an aid to smoking cessation
unjustified.]. Ned Tijdschr Geneeskd 2001;2001(145):31.
14. Kwan AL, et al. Risico op convulsies bij gebruik van bupropion
als hulpmiddel bij het stoppen met roken. [Risk of convulsions
due to the use of bupropion as an aid for smoking cessation.].
Ned Tijdschr Geneeskd 2001;145(6):277–8.
15. Wagena EJ, Knipschild P, Zeegers MPA. Should nortriptyline be
used as a first-line aid to help smokers quit? Results from a
systematic review and meta-analysis. Addiction
2005;100(3):317–26.
16. Fiore MC, et al. Treating tobacco use and dependence. Clinical
practical guideline. Rockville, MD: US Department of Health
and Human Services; 2000.
17. Rice VH, Stead LF, Lancaster T. Nursing interventions for
smoking cessation (Cochrane Review). In: The cochrane library,
Issue 3. Cichester, UK: Wiley; 2004.
18. Adriaanse HP, van Reek J, Rabier JR. Rookgedrag van Neder-
landse huisartsen in de periode 1983–1988. [Smoking behavior
of Dutch family physicians in 1983–1988.]. Ned Tijdschr
Geneeskd 1990;134(31):1502–5.
19. Van Reek J, Adriaanse H. Smoking by physicians in Scandinavia:
1952–1989. Scand J Soc Med 1991;19(4):256–9.
20. Pederson LL. Compliance with physician advice to quit s
moking: a review of the literature. Prev Med 1982;11:
71–84.
21. Smoking and health: physician responsibility. A statement
of the Joint Committee on Smoking and Health. American
College of Chest Physicians. American Thoracic Society.
Asia Pacific Society of Respirology. Canadian Thoracic
Society. European Respiratory Society, and International Union
Against Tuberculosis and Lung Disease. Chest 1995; 108(4):
1118–21.
22. Barengo NC, et al. Changes in smoking prevalence among
Finnish physicians 1990–2001. Eur J Public Health
2004;14(2):201–3.
23. John U, Hanke M. Tobacco-smoking prevalence among physi-
cians and nurses in countries with different tobacco-control
activities. Eur J Cancer Prev 2003;12:235–7.
24. Ohida T, et al. Smoking prevalence and attitudes toward
smoking among Japanese physicians. JAMA 2001;285(20):
2643–8.
